Hypoxic gene expression and metastasis
- PMID: 15197330
- DOI: 10.1023/B:CANC.0000031768.89246.d7
Hypoxic gene expression and metastasis
Abstract
Solid tumors possess malformed vasculature that results in the exposure of tumor cells to a low oxygen environment. Tumor hypoxia has been demonstrated in human and mouse tumors through the use of oxygen microelectrodes, hypoxic specific biomarkers, specific transcriptional changes induced by hypoxia, and secreted proteins. While many elegant experiments have demonstrated that hypoxia enhances metastatic potential, it is still unknown what mechanisms are involved in this enhancement. In this review, we discuss the clinical and basic science studies that support an important role for hypoxia in increasing the metastatic potential of tumor cells by promoting tissue remodeling, inducing angiogenesis and reducing apoptosis. Particular emphasis is given to recent findings that provide insight to the role of hypoxia in the metastatic process.
Similar articles
-
[Metastasis and hypoxia-inducible factor].Gan To Kagaku Ryoho. 2010 Nov;37(11):2047-51. Gan To Kagaku Ryoho. 2010. PMID: 21084801 Review. Japanese.
-
Hypoxia selects for high-metastatic Lewis lung carcinoma cells overexpressing Mcl-1 and exhibiting reduced apoptotic potential in solid tumors.Oncogene. 2006 Feb 9;25(6):917-28. doi: 10.1038/sj.onc.1209128. Oncogene. 2006. PMID: 16247470
-
The tumor bed effect: increased metastatic dissemination from hypoxia-induced up-regulation of metastasis-promoting gene products.Cancer Res. 2005 Mar 15;65(6):2387-96. doi: 10.1158/0008-5472.CAN-04-3039. Cancer Res. 2005. PMID: 15781654
-
Modulation of cell death in the tumor microenvironment.Semin Radiat Oncol. 2003 Jan;13(1):31-41. doi: 10.1053/srao.2003.50004. Semin Radiat Oncol. 2003. PMID: 12520462 Review.
-
Hypoxia-driven selection of the metastatic phenotype.Cancer Metastasis Rev. 2007 Jun;26(2):319-31. doi: 10.1007/s10555-007-9062-2. Cancer Metastasis Rev. 2007. PMID: 17458507 Review.
Cited by
-
MicroRNAs in the imprinted DLK1-DIO3 region repress the epithelial-to-mesenchymal transition by targeting the TWIST1 protein signaling network.J Biol Chem. 2012 Dec 14;287(51):42695-707. doi: 10.1074/jbc.M112.387761. Epub 2012 Oct 26. J Biol Chem. 2012. PMID: 23105110 Free PMC article.
-
Hypoxia-inducible factor-1 as a therapeutic target in endometrial cancer management.Obstet Gynecol Int. 2010;2010:580971. doi: 10.1155/2010/580971. Epub 2010 Feb 14. Obstet Gynecol Int. 2010. PMID: 20169098 Free PMC article.
-
Differential expression of hypoxia-inducible factors related to the invasiveness of epithelial ovarian cancer.Sci Rep. 2021 Nov 25;11(1):22925. doi: 10.1038/s41598-021-02400-1. Sci Rep. 2021. PMID: 34824343 Free PMC article.
-
Phase II study of tirapazamine, cisplatin, and etoposide and concurrent thoracic radiotherapy for limited-stage small-cell lung cancer: SWOG 0222.J Clin Oncol. 2009 Jun 20;27(18):3014-9. doi: 10.1200/JCO.2008.21.3868. Epub 2009 Apr 13. J Clin Oncol. 2009. PMID: 19364954 Free PMC article. Clinical Trial.
-
Derlin-1 is overexpressed in human breast carcinoma and protects cancer cells from endoplasmic reticulum stress-induced apoptosis.Breast Cancer Res. 2008;10(1):R7. doi: 10.1186/bcr1849. Epub 2008 Jan 20. Breast Cancer Res. 2008. PMID: 18205950 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources